3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Conditions
Frailty
3
Neoplasms
2
Stomach Neoplasms
1
Recurrence
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, Myeloid, Acute
1
Dendritic Cell Sarcoma, Interdigitating
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
fludarabine phosphate
3
Cyclophosphamide
3
Antilymphocyte Serum
3
Rituximab
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Methylprednisolone
2
Methotrexate
2
Melphalan
2
Busulfan
2
Weights and Measures
1
Vincristine
1
Thioguanine
1
Tacrolimus
1
Ritonavir
1
Prednisolone
1
Polymerase Chain Reaction
1
Mercaptopurine
1
Magnetic Resonance Spectroscopy
1
Lenalidomide
1
Indinavir
1
Geriatric Assessment
1
Gelclair
1
Flow Cytometry
1
Filgrastim
1
Etoposide
1
Dexamethasone
1
Daunorubicin
1
Cytarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Dendritic Cell Sarcoma, Interdigitating
×
Geriatric Assessment
×
Clear all
NCT04113226
2023-02-08
Relyage
Centre Hospitalier Universitaire, Amiens
Phase 2
Unknown
114 enrolled